Narayana Hrudayalaya Ltd Share Price Narayana Hrudaya

203.15

Open ()
Turnover (lac)
Prev. Close ()
Day's Vol.(shares)

204.60

Open ()
Turnover (lac)
Prev. Close ()
Day's Vol.(shares)
Detailed Quote
Chairman & Exec. Director DEVI PRASAD SHETTY
Managing Director & CEO Ashutosh Raghuvanshi
Whole-time Director Viren Shetty
Director Kiran Mazumdar Shaw
Independent Director Dinesh Krishna Swamy
Independent Director B Muthuraman
Independent Director B N Subramanya
Independent Director Manohar D Chatlani
Company Secretary Sridhar S
Independent Director Arun Seth

Narayana Hrudayalaya Limited was founded in 2000 by Dr. Devi Prasad Shetty. The company is the leading private healthcare service providers in India, operating a chain of multispecialty, tertiary and primary healthcare facilities. The companys first facility was established in Bengaluru with approximately 225 operational beds. As of 1 May 2018, Narayana Hrudayalaya operates 24 hospitals (multispeciality and superspeciality healthcare facilities which provide tertiary care), 7 heart centres (superspeciality units which are set up in a third party hospital), 19 primary care facilities (including clinics and information centres) and a multi-speciality hospital in Cayman Islands adding up to 6,232 operational beds.During the financial year ended 31 March 2016, Narayana Hrydayalaya acquired the entire remaining 26% in Narayana Hrudayalaya Surgical Hospital Private Limited (NHSHPL) from Infrastructure Development Corporation (Karnataka) Limited (IDECK) by paying Rs 3,025.60 Lacs as total purchase consideration to make NHSHPL as its wholly owned subsidiary. During the year under review, the company through its wholly owned subsidiary entered into an agreement with prominent Kenyan doctors and couple of leading international financial institutions to establish a multi-specialty hospital in Nairobi, Kenya. The company through its wholly owned subsidiary would initially own 26% equity stake in the operational entity for a consideration of USD 1.325 million. The multi-specialty hospital will be a state of the art tertiary care facility poised to cater to patients across different specialties. The 130 bedded hospital will provide affordable quality care that Narayana stands for, to the patients from Kenya and neighbouring African countries. During the year under review, the company received National Accreditation Board for Hospitals & Healthcare Providers (NABH) accreditation for 5 new units viz. HSR, Guwahati, Ahmedabad, Jamshedpur and Mysore.Asia Healthcare Development Limited (AHDL) was a wholly owned subsidiary of the Company which was engaged in the business of operation of hospitals, clinics, health centers, nursing homes and other related activities. The Company was sold in November 2016 to Lila Hospitals Private Limited by executing a Share Purchase Agreement for the sale of all its shares for a consideration of Rs. 38.34 lacs.The promoters and promoter group of the company other share holders (JP Morgan Mauritius Holdings, Ambadevi Mauritius Holdings, Ashoka Investment Holdings) offloaded a total of 2.45 crore equity shares of Narayana Hrudayalaya by way of an initial public offer (IPO). The IPO was open for subscription during the period from 17 to 21 December 2015. There was no fresh issue of shares from the company. The company got its securities listed on BSE Limited and on National Stock Exchange of India Limited on 6 January 2016.At the beginning of the financial year ended 31 March 2017, Narayana Hrydayalaya made significant investments by acquiring NewRise Healthcare Private Limited from Panacea Biotech Limited at an enterprise value of Rs 180 crore. On the organic route, the company started fiscal 2016-17 with the commissioning of its super speciality facility at Kakriyal, Jammu (established in partnership with Shri Mata Vaishno Devi Shrine Board). The 230 bedded facility is a state-of-the-art tertiary care facility catering to patients across 20 different specialities with a particular focus on cardiac sciences and oncologyPursuant to a Share Purchase Agreement executed in November 2016, Asia Healthcare Development Limited was sold to Lila Hospitals Private Limited. Narayana Hrydayalayas subsidiary Narayana Hrudayalaya Hospitals Malaysia Sdn Bhd (Narayana Malaysia) filed an application for voluntary liquidation, pursuant to Section 257(1) of the Companies Act, 1965 of Malaysia in January 2017.During the financial year ended 31 March 2017, the company launched a dedicated 30 bedded platinum wing in Mazumdar Shaw Medical Centre, Bengaluru to offer world-class services and comfort in line with international standards of dedicated care and hospitality. During the year under review, the company partnered with Cisco to offer affordable remote diagnostic capabilities; this digital telemedicine solution would deliver advanced specialized healthcare services remotely in various parts of the country.Narayana Hrydayalayas wholly owned subsidiary Narayana Hrudayalaya Surgical Hospital Private Limited (NHSHPL) entered into a Healthcare Services Agreement in March 2017 with Dharamshila Cancer Foundation and Research Centre for operating a hospital in New Delhi. NHSHPL is engaged in the business of operating and maintaining hospitals, clinics, health centers, nursing homes and other related activities.Towards the beginning the financial year ended 31 March 2018, the company commissioned SRCC Childrens Hospital at Haji Ali Park, Mahalaxmi in Mumbai. The facility is operated and managed by Narayana Hrydayalaya and backed by SRCC, an institution renowned for serving the needs of children from all sections of society. SRCC Childrens Hospital is the companys maiden foray in Mumbai and a well-calibrated step in line with the group strategy to reinforce its presence across selected regional clusters. Narayana Hrydayalaya also acquired) a ~230 bedded near complete hospital at Gurugram in early 2017-18.During the financial year ended 31 March 2018, NewRise Healthcare Private Limited (NRHPL) was merged with the company vide Regional Directors Order dated 4 October 2017. NRHPL was a wholly owned subsidiary of the company which was acquired from Panacea Biotech Limited during the year under review. Health City Cayman Islands Ltd (HCCI) is a company incorporated in Cayman Islands and operates a hospital in Cayman Islands. Narayana Hrydayalaya held 28.6% equity shares in HCCI through its wholly owned subsidiary Narayana Cayman Holdings Limited (NCHL) and the balance 71.4% of the shares of HCCI was held by Ascension Health Ventures LLC, USA, (AHV) an affiliate of Ascension Health Alliance, USA (AHA). HCCI bought back 71.4% held by AHV during the year under review. Consequent to this buy back, HCCI, became a 100% step down subsidiary of company. Buoyed by the strong patients response from neighbouring areas including Bangladesh, the company commissioned 2nd LINAC at Westbank in June 2017. During the financial year ended 31 March 2018, the company expanded its reach in northern and western clusters.

REGISTERED OFFICE

No 258/A Bommasandra Indl Area,
Anekal Taluq,Bengaluru,
Karnataka-560099

Tell. : +91-80-71222802
Website : http://www.narayanahealth.org
Email : investorrelations@narayanahealth.org

REGISTRAR OFFICE

Karvy Selenium Tow-B,
Nanakramguda,Hyderabad-500032
INDIA

Tell. : +91-40-67161500
Website : www.karvyfintech.com
Email : einward.ris@karvy.com